Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan I Basbaum

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Nature|December 9, 2021
Structures of the σ<sub>2</sub> receptor enable docking for bioactive ligand discoveryAssaf Alon, Jiankun Lyu, Joao M Braz, et al.
Nature Reviews. Neuroscience|May 17, 2018
Transition to chronic pain: opportunities for novel therapeuticsTheodore J Price, Allan I Basbaum, Jacqueline Bresnahan, et al.
Science Advances|June 18, 2025
Discovery of a functionally selective serotonin receptor (5-HT<sub>1A</sub>R) agonist for the treatment of painAnnika Ullrich, Johannes Schneider, João M Braz, et al.
Nature Communications|December 6, 2023
Docking for EP4R antagonists active against inflammatory painStefan Gahbauer, Chelsea DeLeon, Joao M Braz, et al.
Cell|May 3, 2023
Structure-based discovery of conformationally selective inhibitors of the serotonin transporterIsha Singh, Anubha Seth, Christian B Billesbølle, et al.
Nature|June 10, 2016
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical painJeremiah D Osteen, Volker Herzig, John Gilchrist, et al.
Science (New York, N.Y.)|September 29, 2022
Structure-based discovery of nonopioid analgesics acting through the α<sub>2A</sub>-adrenergic receptorElissa A Fink, Jun Xu, Harald Hübner, et al.
Journal of Medicinal Chemistry|February 19, 2026
Large Library Docking for PolypharmacologyYujin Wu, Seth Vigneron, Joao Braz, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Toward a Random Background for Ligand OptimizationXinyu Xu, Olivier Mailhot, Galen J Correy, et al.
Nature Communications|March 5, 2025
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Nature|December 9, 2021
Structures of the σ<sub>2</sub> receptor enable docking for bioactive ligand discoveryAssaf Alon, Jiankun Lyu, Joao M Braz, et al.
Nature Reviews. Neuroscience|May 17, 2018
Transition to chronic pain: opportunities for novel therapeuticsTheodore J Price, Allan I Basbaum, Jacqueline Bresnahan, et al.
Science Advances|June 18, 2025
Discovery of a functionally selective serotonin receptor (5-HT<sub>1A</sub>R) agonist for the treatment of painAnnika Ullrich, Johannes Schneider, João M Braz, et al.
Nature Communications|December 6, 2023
Docking for EP4R antagonists active against inflammatory painStefan Gahbauer, Chelsea DeLeon, Joao M Braz, et al.
Cell|May 3, 2023
Structure-based discovery of conformationally selective inhibitors of the serotonin transporterIsha Singh, Anubha Seth, Christian B Billesbølle, et al.
Nature|June 10, 2016
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical painJeremiah D Osteen, Volker Herzig, John Gilchrist, et al.
Science (New York, N.Y.)|September 29, 2022
Structure-based discovery of nonopioid analgesics acting through the α<sub>2A</sub>-adrenergic receptorElissa A Fink, Jun Xu, Harald Hübner, et al.
Journal of Medicinal Chemistry|February 19, 2026
Large Library Docking for PolypharmacologyYujin Wu, Seth Vigneron, Joao Braz, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Toward a Random Background for Ligand OptimizationXinyu Xu, Olivier Mailhot, Galen J Correy, et al.
Nature Communications|March 5, 2025
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Pageof 15